Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 31,800 | 0.00 | 77,800 |
17 Jan 25 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 6.16 | 63,500 | 391.16 k | 63,500 |
12 Jul 24 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 46,000 | 0.00 | 46,000 |
12 Jul 24 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.47 | 170,000 | 2.12 mm | 170,000 |
21 Feb 24 | VYGR Voyager Therapeutics | Common Stock | Sell | Dispose S | No | No | 7.46 | 3,764 | 28.08 k | 175,669 |
9 Feb 24 | VYGR Voyager Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 179,433 |
9 Feb 24 | VYGR Voyager Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.6 | 60,000 | 456.00 k | 60,000 |